| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.094 | 0.007 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.007 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.095 | 0.008 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.009 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |